Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access

American Journal of Infection Control

Volumn 42, Issue 10, 2014, Pages 1130-1132

  Lorente, Leonardo ^a   Lecuona, María ^a   Jiménez, Alejandro ^a   Lorenzo, Lisset ^a   Diosdado, Sara ^a   Marca, Lucía ^a   Mora, María L ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Bacteremia; Central venous catheter

Indexed keywords

ANTIINFECTIVE AGENT; CORTICOSTEROID; CHLORHEXIDINE; DISINFECTANT AGENT; SULFADIAZINE SILVER;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHLORHEXIDINE SILVER SULFADIAZINE IMPREGNATED VENOUS CATHETER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DRUG USE; FEMALE; FEMORAL VEIN; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SOLID TUMOR; TRACHEOSTOMY; TREATMENT DURATION; VASCULAR ACCESS; AGED; CATHETER-RELATED INFECTIONS; CATHETERIZATION; ECONOMICS; INFECTION CONTROL; MIDDLE AGED; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CATHETER-RELATED INFECTIONS; CATHETERIZATION; CENTRAL VENOUS CATHETERS; CHLORHEXIDINE; COST-BENEFIT ANALYSIS; DISINFECTANTS; FEMALE; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SILVER SULFADIAZINE;

EID: 84908156409     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2014.06.027     Document Type: Article

References (23)

1. J.L. Vincent, D.J. Bihari, P.M. Suter, H.A. Bruining, J. White, and M.H. Nicolas-Chanoin The prevalence of nosocomial infection in Intensive Care Units in EuropeResults of the European Prevalence of Infection in Intensive Care (EPIC) Study.The EPIC International Advisory Committee JAMA 274 1995 639 644
2. I.I. Siempos, P. Kopterides, I. Tsangaris, I. Dimopoulou, and A.E. Armaganidis Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis Crit Care Med 37 2009 2283 2289
3. M.L. Lambert, C. Suetens, A. Savey, M. Palomar, M. Hiesmayr, and I. Morales Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study Lancet Infect Dis 11 2011 30 38
4. K.B. Laupland, H. Lee, D.B. Gregson, and B.J. Manns Cost of intensive care unit-acquired bloodstream infections J Hosp Infect 63 2006 124 132
5. D.L. Veenstra, S. Saint, S. Saha, T. Lumley, and S.D. Sullivan Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis JAMA 281 1999 261 267
6. J.C. Hockenhull, K. Dwan, A. Boland, G. Smith, A. Bagust, and Y. Dündar The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation Health Technol Assess 12 2008 1 154
7. D.L. Veenstra, S. Saint, and S.D. Sullivan Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection JAMA 282 1999 554 560
8. A.F. Shorr, C.W. Humphreys, and D.L. Helman New choices for central venous catheters: potential financial implications Chest 124 2003 275 284
9. D. Pittet, D. Tarara, and R.P. Wenzel Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality JAMA 271 1994 1598 1601
10. J.B. Dimick, R.K. Pelz, R. Consunji, S.M. Swoboda, C.W. Hendrix, and P.A. Lipsett Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit Arch Surg 136 2001 229 234
11. D.G. Maki, C.E. Weise, and H.W. Sarafin A semiquantitative culture method for identifying intravenous catheter-related infection N Engl J Med 296 1977 1305 1309
12. L. Lorente, M. Lecuona, A. Jiménez, R. Santacreu, L. Raja, and O. González Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs Am J Infect Control 42 2014 321 324
13. L. Lorente, M. Lecuona, M.J. Ramos, A. Jiménez, M.L. Mora, and A. Sierra The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia Clin Infect Dis 47 2008 1171 1175
14. L. Lorente, M. Lecuona, M.J. Ramos, A. Jiménez, M.L. Mora, and A. Sierra Lower assistance costs using rifampicin-miconazole-impregnated catheters than standard catheters Am J Infect Control 39 2011 895 897
15. L. Lorente, M. Lecuona, M.J. Ramos, A. Jiménez, M.L. Mora, and A. Sierra Rifampicin-miconazole-impregnated catheters save cost in jugular venous sites with tracheostomy Eur J Clin Microbiol Infect Dis 31 2012 1833 1836
16. N.P. O'Grady, M. Alexander, L.A. Burns, E.P. Dellinger, J. Garland, S.O. Heard Healthcare Infection Control Practices Advisory Committee (HICPAC) Guidelines for the prevention of intravascular catheter-related infections Clin Infect Dis 52 2011 e162 e193
17. L. Lorente, C. Henry, M.M. Martín, A. Jiménez, and M.L. Mora Central venous catheter-related infection in a prospective and observational study of 2595 catheters Crit Care 9 2005 R631 R635
18. T. Oda, J. Hamasaki, N. Kanda, and K. Mikami Anaphylactic shock induced by an antiseptic-coated central venous [correction of nervous] catheter Anesthesiology 87 1997 1242 1244
19. E. Terazawa, H. Shimonaka, K. Nagase, T. Masue, and S. Dohi Severe anaphylactic reaction due to a chlorhexidine-impregnated central venous catheter Anesthesiology 89 1998 1296 1298
20. R. Stephens, M. Mythen, P. Kallis, D.W. Davies, W. Egner, and A. Rickards Two episodes of life-threatening anaphylaxis in the same patient to a chlorhexidine-sulphadiazine-coated central venous catheter Br J Anaesth 87 2001 306 308
21. R. Jee, L. Nel, G. Gnanakumaran, A. Williams, and E. Eren Four cases of anaphylaxis to chlorhexidine impregnated central venous catheters: a case cluster or the tip of the iceberg? Br J Anaesth 103 2009 614 615
22. L.A. Sampath, S.M. Tambe, and S.M. Modak In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters Infect Control Hosp Epidemiol 22 2001 640 646
23. S.M. Tambe, L. Sampath, and S.M. Modak In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices J Antimicrob Chemother 47 2001 589 598